Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

COCHLEAR LIMITED Director's Dealing 2018

Oct 30, 2018

64685_rns_2018-10-30_329a78e9-4934-454d-a429-465c7f731840.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Cochlear Limited
ABN 96 002 618 073

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Diggory William Howitt

Date of last notice 30 August 2018

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. Not applicable
Date of change 25 October 2018
No. of securities held prior to change (a) 32,066 Shares(b) 13,028 Options(c) 57,217 LTI Options(d) 4,909 LTI Performance Rights(e) 2,641 STI Deferral Performance Rights
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

(a)fully paid ordinary shares in (a)fully paid ordinary shares in (a)fully paid ordinary shares in
Cochlear Lim ited (“Shares”)r Shares (“Options”)
(b)ti
opons ove
(c)long term in centive Options subjectnce hurdles and vestin
to erforma
ptimeframes g(“LTI Options”)
(d)long term incentive Share rights
subject to performance hurdles andvestintimeframes(“LTI
g
Performanc e Rights)
(e)short termsubject to a incentive Share rightsvestin timeframe (“STI
gDeferral Performance Rights”)
Number acquired
4,215 Shares
Number disposed
Value/ConsiderationNote: If consideration is non-cash,No. of securities held after provide details and estimated valuation 4,215 Options exercis ed at $82.89 per Share
change (a) 36,281 Shares(b) 8,813 Options
(c) 57217 LTI Options
,
(d) 4,909 LTI Perform nce Rights
(e) 2641 STI Deferral Performance Rights
,
Nature of changeExample: on-market tradesecurities under dividend r
, off-mareinvestm ket trade, exercise of options, issue oent plan, participation in buy-back f Exercise of OptionCochlear Executive In s granted under thecentive Plan (CEIP).
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder(if issued securities) N/A
Date of change N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relationto which the interest has changed N/A
Interest acquired N/A
Interest disposed N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation N/A
Interest after change N/A

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed abovetraded during a+closed period where prior written clearance wasrequired? No
If so, was prior written clearance provided to allow the trade toproceed during this period? Not applicable
If prior written clearance was provided, on what date was thisprovided? Not applicable
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3